262 related articles for article (PubMed ID: 32655554)
21. TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.
Li W; Li F; Lei W; Tao Z
Cell Commun Signal; 2019 Dec; 17(1):162. PubMed ID: 31823782
[TBL] [Abstract][Full Text] [Related]
22. Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors.
Nisticò P; Ciliberto G
Int J Biol Markers; 2020 Feb; 35(1_suppl):8-11. PubMed ID: 32079468
[TBL] [Abstract][Full Text] [Related]
23. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
Sloot YJE; Rabold K; Ulas T; De Graaf DM; Heinhuis B; Händler K; Schultze JL; Netea MG; Smit JWA; Joosten LAB; Netea-Maier RT
Cell Oncol (Dordr); 2019 Oct; 42(5):691-703. PubMed ID: 31201646
[TBL] [Abstract][Full Text] [Related]
24. Systematic review of the roles of interleukins in hepatocellular carcinoma.
Yang H; Xuefeng Y; Jianhua X
Clin Chim Acta; 2020 Jul; 506():33-43. PubMed ID: 32142718
[TBL] [Abstract][Full Text] [Related]
25. Long Non-Coding RNA ZFAS1 as a Novel Potential Biomarker for Predicting the Prognosis of Thyroid Cancer.
Han CG; Huang Y; Qin L
Med Sci Monit; 2019 Apr; 25():2984-2992. PubMed ID: 31012438
[TBL] [Abstract][Full Text] [Related]
26. Cytokines, thyroid diseases and thyroid cancer.
Lumachi F; Basso SM; Orlando R
Cytokine; 2010 Jun; 50(3):229-33. PubMed ID: 20381375
[TBL] [Abstract][Full Text] [Related]
27. [Dormancy of tumor cells].
Strien L; Joensuu K; Heikkilä P
Duodecim; 2013; 129(21):2245-52. PubMed ID: 24340675
[TBL] [Abstract][Full Text] [Related]
28. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis.
Ribatti D
Immunol Lett; 2013 May; 152(2):83-8. PubMed ID: 23685256
[TBL] [Abstract][Full Text] [Related]
29. The role of cytokines in breast cancer development and progression.
Esquivel-Velázquez M; Ostoa-Saloma P; Palacios-Arreola MI; Nava-Castro KE; Castro JI; Morales-Montor J
J Interferon Cytokine Res; 2015 Jan; 35(1):1-16. PubMed ID: 25068787
[TBL] [Abstract][Full Text] [Related]
30. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment.
Wu F; Li F; Lin X; Xu F; Cui RR; Zhong JY; Zhu T; Shan SK; Liao XB; Yuan LQ; Mo ZH
Endocr Relat Cancer; 2019 May; 26(5):525-538. PubMed ID: 30870812
[TBL] [Abstract][Full Text] [Related]
31. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
33. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition.
Ye D; Jiang Y; Sun Y; Li Y; Cai Y; Wang Q; Wang O; Chen E; Zhang X
J Mol Endocrinol; 2019 Jul; 63(1):51-61. PubMed ID: 31121562
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization.
Lee CC; Lin JC; Hwang WL; Kuo YJ; Chen HK; Tai SK; Lin CC; Yang MH
Nat Commun; 2018 Sep; 9(1):3763. PubMed ID: 30218063
[TBL] [Abstract][Full Text] [Related]
36. [Interleukin-33: Friend or Enemy in the Fight against Tumors?].
Gorbacheva AM; Mitkin NA
Mol Biol (Mosk); 2019; 53(5):774-789. PubMed ID: 31661477
[TBL] [Abstract][Full Text] [Related]
37. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
[TBL] [Abstract][Full Text] [Related]
38. New insights into the role of EMT in tumor immune escape.
Terry S; Savagner P; Ortiz-Cuaran S; Mahjoubi L; Saintigny P; Thiery JP; Chouaib S
Mol Oncol; 2017 Jul; 11(7):824-846. PubMed ID: 28614624
[TBL] [Abstract][Full Text] [Related]
39. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
40. Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments.
Febrero B; Ruiz-Manzanera JJ; Ros-Madrid I; Hernández AM; Orenes-Piñero E; Rodríguez JM
Head Neck; 2024 Jun; 46(6):1486-1499. PubMed ID: 38380767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
